<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31439573</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1754-8411</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>Disease models &amp; mechanisms</Title><ISOAbbreviation>Dis Model Mech</ISOAbbreviation></Journal><ArticleTitle><i>C9ORF72</i>-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dmm039552</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1242/dmm.039552</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a late-onset neuromuscular disease with no cure and limited treatment options. Patients experience a gradual paralysis leading to death from respiratory complications on average only 2-5&#x2005;years after diagnosis. There is increasing evidence that skeletal muscle is affected early in the disease process, yet the pathological processes occurring in the skeletal muscle of ALS patients are still mostly unknown. Specifically, the most common genetic cause of ALS, a hexanucleotide repeat expansion in the <i>C9ORF72</i> gene, has yet to be fully characterized in the context of skeletal muscle. In this study, we used the protocol previously developed in our lab to differentiate skeletal myocytes from induced pluripotent stem cells (iPSCs) of <i>C9ORF72</i> ALS (C9-ALS) patients in order to create an <i>in vitro</i> disease model of C9-ALS skeletal muscle pathology. Of the three <i>C9ORF72</i> mutation hallmarks, we did not see any evidence of haploinsufficiency, but we did detect RNA foci and dipeptide repeat (DPR) proteins. Additional abnormalities included changes in the expression of mitochondrial genes and a susceptibility to oxidative stress, indicating that mitochondrial dysfunction may be a critical feature of C9-ALS skeletal muscle pathology. Finally, the C9-ALS myocytes had increased expression and aggregation of TDP-43. Together, these data show that skeletal muscle cells experience pathological changes due to the <i>C9ORF72</i> mutation. Our <i>in vitro</i> model could facilitate further study of cellular and molecular pathology in ALS skeletal muscle in order to discover new therapeutic targets against this devastating disease.This article has an associated First Person interview with the first author of the paper.</AbstractText><CopyrightInformation>&#xa9; 2019. Published by The Company of Biologists Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Eileen</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0214-5046</Identifier><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semrad</LastName><ForeName>Theran</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2663-5867</Identifier><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belsito</LastName><ForeName>Vincent S</ForeName><Initials>VS</Initials><Identifier Source="ORCID">0000-0002-4951-2416</Identifier><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>FitzGibbons</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7241-2387</Identifier><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reilly</LastName><ForeName>Megan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6586-2547</Identifier><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayakawa</LastName><ForeName>Koji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0453-1303</Identifier><AffiliationInfo><Affiliation>Department of Toxicology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime 794-8555, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Masatoshi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3253-0711</Identifier><AffiliationInfo><Affiliation>Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA masatoshi.suzuki@wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stem Cell and Regenerative Medicine Center, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS091540</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dis Model Mech</MedlineTA><NlmUniqueID>101483332</NlmUniqueID><ISSNLinking>1754-8403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057895" MajorTopicYN="N">Haploinsufficiency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Skeletal muscle</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">iPSCs</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31439573</ArticleId><ArticleId IdType="pmc">PMC6737948</ArticleId><ArticleId IdType="doi">10.1242/dmm.039552</ArticleId><ArticleId IdType="pii">12/8/dmm039552</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Saif A., Al-Mohanna F. and Bohlega S. (2011). A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 70, 913-919. 10.1002/ana.22534</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S., Gascon E., Tran H., Chou H. J., Gendron T. F., Degroot S., Tapper A. R., Sellier C., Charlet-Berguerand N., Karydas A. et al. (2013). Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 126, 385-399. 10.1007/s00401-013-1149-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1149-y</ArticleId><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J., Roczniak-Ferguson A. and Ferguson S. M. (2016). C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol. Biol. Cell 27, 3040-3051. 10.1091/mbc.e16-01-0003</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e16-01-0003</ArticleId><ArticleId IdType="pmc">PMC5063613</ArticleId><ArticleId IdType="pubmed">27559131</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh R. H. (2011). TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. FEBS J. 278, 3539-3549. 10.1111/j.1742-4658.2011.08256.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2011.08256.x</ArticleId><ArticleId IdType="pmc">PMC3177991</ArticleId><ArticleId IdType="pubmed">21777387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M. F., Hofmann S., Neupert W. and Brunner M. (2000). Protein translocation into mitochondria: the role of TIM complexes. Trends Cell Biol. 10, 25-31. 10.1016/S0962-8924(99)01684-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(99)01684-0</ArticleId><ArticleId IdType="pubmed">10603473</ArticleId></ArticleIdList></Reference><Reference><Citation>Briston T. and Hicks A. R. (2018). Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention. Biochem. Soc. Trans. 46, 829-842. 10.1042/BST20180025</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20180025</ArticleId><ArticleId IdType="pmc">PMC6103456</ArticleId><ArticleId IdType="pubmed">29986938</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R. H. and Al-Chalabi A. (2017). Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 1602 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckingham M. and Mayeuf A. (2012). Skeletal muscle development. In: Muscle (ed. Hill J. A. and Olson E. N.), pp. 749-762. Academic Press.</Citation></Reference><Reference><Citation>Burberry A., Suzuki N., Wang J. Y., Moccia R., Mordes D. A., Stewart M. H., Suzuki-Uematsu S., Ghosh S., Singh A., Merkle F. T. et al. (2016). Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 8, 347ra393 10.1126/scitranslmed.aaf6038</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V. and Francolini M. (2017). Neuromuscular junction dismantling in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 18, 2092 10.3390/ijms18102092</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102092</ArticleId><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M. T., D'Ambrosi N. and Cozzolino M. (2017). Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochem. Biophys. Res. Commun. 483, 1187-1193. 10.1016/j.bbrc.2016.07.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Chal J. and Pourqui&#xe9; O. (2017). Making muscle: skeletal myogenesis in vivo and in vitro. Development 144, 2104-2122. 10.1242/dev.151035</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.151035</ArticleId><ArticleId IdType="pubmed">28634270</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S. Y., Lopez-Gonzalez R., Krishnan G., Phillips H. L., Li A. N., Seeley W. W., Yao W.-D., Almeida S. and Gao F.-B. (2019). C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 22, 851-862. 10.1038/s41593-019-0397-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.-C., Zhang Y., Umoh M. E., Vaughan S. W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P. G., Chen Y. H., Duong D. M. et al. (2018). TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 21, 228-239. 10.1038/s41593-017-0047-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E. G., Lu L., Sharma A., Yamazaki T., Tang T., Shneider N. A. and Manley J. L. (2016). The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. eLife 5, e17820 10.7554/eLife.17820</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M. J., Higginbottom A., Robin Highley J., Dickman M. J., Edbauer D., Ince P. G., Wharton S. B., Wilson S. A., Kirby J. et al. (2014). Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain 137, 2040-2051. 10.1093/brain/awu120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Bury J. J., Heath P. R., Wyles M., Higginbottom A., Gelsthorpe C., Highley J. R., Hautbergue G., Rattray M., Kirby J., et al. (2015). C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis. PLoS ONE 10, e0127376 10.1371/journal.pone.0127376</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127376</ArticleId><ArticleId IdType="pmc">PMC4446097</ArticleId><ArticleId IdType="pubmed">26016851</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Couratier P., Blasco H., Andres C. R., Beltran S., Meininger V. and Vourc'h P. (2017). Genetics of amyotrophic lateral sclerosis. Rev. Neurol. (Paris) 173, 254-262. 10.1016/j.neurol.2017.03.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.03.030</ArticleId><ArticleId IdType="pubmed">28449881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski M. D., Powell S. Z., Appel J. W., Arumanayagam A. S., Rivera A. L. and Appel S. H. (2018). Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 6, 28 10.1186/s40478-018-0528-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0528-y</ArticleId><ArticleId IdType="pmc">PMC5899326</ArticleId><ArticleId IdType="pubmed">29653597</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejesus-Hernandez M., Mackenzie I. R., Boeve B. F., Boxer A. L., Baker M., Rutherford N. J., Nicholson A. M., Finch N. C. A., Flynn H., Adamson J. et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256. 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert A. D., Shelley B. C., Hurley A. M., Onorati M., Castiglioni V., Patitucci T. N., Svendsen S. P., Mattis V. B., Mcgivern J. V., Schwab A. J. et al. (2013). EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs. Stem Cell Res. 10, 417-427. 10.1016/j.scr.2013.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2013.01.009</ArticleId><ArticleId IdType="pmc">PMC3786426</ArticleId><ArticleId IdType="pubmed">23474892</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M. A., Sundaramoorthy V., Sultana J. M., Yang S., Atkinson R. A. K., Levina V., Halloran M. A., Gleeson P. A., Blair I. P., Soo K. Y. et al. (2014). C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 23, 3579-3595. 10.1093/hmg/ddu068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A. J., Sendtner M. and Shaw P. J. (2011). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630. 10.1038/nrneurol.2011.152</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L. R., Culver D. G., Tennant P., Davis A. A., Wang M., Castellano-Sanchez A., Khan J., Polak M. A. and Glass J. D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B. D. and Taylor J. P. (2017). The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front. Mol. Neurosci. 10, 35 10.3389/fnmol.2017.00035</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M. L., Perry G. and Wang X. (2018). Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. 146, 7-20. 10.1111/jnc.14327</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Halter B., Gonzalez De Aguilar J.-L., Rene F., Petri S., Fricker B., Echaniz-Laguna A., Dupuis L., Larmet Y. and Loeffler J.-P. (2010). Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 48, 915-923. 10.1016/j.freeradbiomed.2010.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.01.014</ArticleId><ArticleId IdType="pubmed">20079427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoyama T., Mcgivern J. V., Van Dyke J. M., Ebert A. D. and Suzuki M. (2014). Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl. Med. 3, 564-574. 10.5966/sctm.2013-0143</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2013-0143</ArticleId><ArticleId IdType="pmc">PMC4006483</ArticleId><ArticleId IdType="pubmed">24657962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiwlawat S., Lynch E., Glaser J., Smit-Oistad I., Jeffrey J., Van Dyke J. M. and Suzuki M. (2017). Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture. Differentiation 96, 70-81. 10.1016/j.diff.2017.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diff.2017.07.004</ArticleId><ArticleId IdType="pmc">PMC5669825</ArticleId><ArticleId IdType="pubmed">28915407</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiwlawat N., Lynch E., Jeffrey J., Van Dyke J. M. and Suzuki M. (2018). Current progress and challenges for skeletal muscle differentiation from human pluripotent stem cells using transgene-free approaches. Stem Cells Int. 2018, 6241681 10.1155/2018/6241681</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6241681</ArticleId><ArticleId IdType="pmc">PMC5924987</ArticleId><ArticleId IdType="pubmed">29760730</ArticleId></ArticleIdList></Reference><Reference><Citation>Keating D. J. (2008). Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. J. Neurochem. 104, 298-305. 10.1111/j.1471-4159.2007.04997.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04997.x</ArticleId><ArticleId IdType="pubmed">17961149</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B. and Li&#xe9;vens J.-C. (2017). Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway? Neural Regen. Res. 12, 1052-1061. 10.4103/1673-5374.211179</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.211179</ArticleId><ArticleId IdType="pmc">PMC5558479</ArticleId><ArticleId IdType="pubmed">28852382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodaka Y., Rabu G. and Asakura A. (2017). Skeletal muscle cell induction from pluripotent stem cells. Stem Cells Int. 2017, 1376151 10.1155/2017/1376151</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1376151</ArticleId><ArticleId IdType="pmc">PMC5424488</ArticleId><ArticleId IdType="pubmed">28529527</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakora D., Macrander C. and Suzuki M. (2012). Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurol Res. Int. 2012, 379657 10.1155/2012/379657</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/379657</ArticleId><ArticleId IdType="pmc">PMC3423938</ArticleId><ArticleId IdType="pubmed">22919482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-B., Chen H.-J., Peres J. N., Gomez-Deza J., Attig J., &#x160;talekar M., Troakes C., Nishimura A. L., Scotter E. L., Vance C. et al. (2013). Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 5, 1178-1186. 10.1016/j.celrep.2013.10.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J., Pagani F., De Santis R., Limatola C., Bozzoni I., Di Angelantonio S. and Rosa A. (2016). Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases. Stem Cell Res. 17, 140-147. 10.1016/j.scr.2016.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2016.06.003</ArticleId><ArticleId IdType="pmc">PMC5009183</ArticleId><ArticleId IdType="pubmed">27318155</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine T. P., Daniels R. D., Gatta A. T., Wong L. H. and Hayes M. J. (2013). The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics 29, 499-503. 10.1093/bioinformatics/bts725</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts725</ArticleId><ArticleId IdType="pmc">PMC3570213</ArticleId><ArticleId IdType="pubmed">23329412</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Strykowski R., Meyer M., Mulcrone P., Krakora D. and Suzuki M. (2012). Male-specific differences in proliferation, neurogenesis, and sensitivity to oxidative stress in neural progenitor cells derived from a rat model of ALS. PLoS ONE 7, e48581 10.1371/journal.pone.0048581</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048581</ArticleId><ArticleId IdType="pmc">PMC3493558</ArticleId><ArticleId IdType="pubmed">23144905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S. C. (2018). Synaptic paths to neurodegeneration: the emerging role of TDP-43 and FUS in synaptic functions. Neural Plast. 2018, 8413496 10.1155/2018/8413496</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8413496</ArticleId><ArticleId IdType="pmc">PMC5925147</ArticleId><ArticleId IdType="pubmed">29755516</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pattamatta A., Zu T., Reid T., Bardhi O., Borchelt D. R., Yachnis A. T. and Ranum L. P. W. (2016). C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron 90, 521-534. 10.1016/j.neuron.2016.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler J.-P., Picchiarelli G., Dupuis L. and Gonzalez De Aguilar J.-L. (2016). The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 26, 227-236. 10.1111/bpa.12350</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T. F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B. L., Almeida S. and Gao F.-B. (2016). Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 92, 383-391. 10.1016/j.neuron.2016.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig T. E., Bergendahl V., Levenstein M. E., Yu J., Probasco M. D. and Thomson J. A. (2006a). Feeder-independent culture of human embryonic stem cells. Nat. Methods 3, 637-646. 10.1038/nmeth902</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth902</ArticleId><ArticleId IdType="pubmed">16862139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig T. E., Levenstein M. E., Jones J. M., Berggren W. T., Mitchen E. R., Frane J. L., Crandall L. J., Daigh C. A., Conard K. R., Piekarczyk M. S. et al. (2006b). Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187. 10.1038/nbt1177</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1177</ArticleId><ArticleId IdType="pubmed">16388305</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T. G., Partridge L. and Isaacs A. M. (2017). Genetic models of C9orf72: what is toxic? Curr. Opin. Genet. Dev. 44, 92-101. 10.1016/j.gde.2017.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.01.006</ArticleId><ArticleId IdType="pubmed">28364657</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E. B., De Winter F. and Verhaagen J. (2014). ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 8, 252 10.3389/fnins.2014.00252</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., Bruce J., Schuck T., Grossman M., Clark C. M. et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L. K., Sampathu D. M., Trojanowski J. Q. and Lee V. M.-Y. (2007). TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch. Neurol. 64, 1388-1394. 10.1001/archneur.64.10.1388</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.10.1388</ArticleId><ArticleId IdType="pubmed">17923623</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberstadt M., Cla&#xdf;en J., Arendt T. and Holzer M. (2018). TDP-43 and cytoskeletal proteins in ALS. Mol. Neurobiol. 55, 3143-3151. 10.1007/s12035-017-0543-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0543-1</ArticleId><ArticleId IdType="pubmed">28466273</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe9; M., Janu&#xe9; A., Moreno D., G&#xe1;mez J., Torrej&#xf3;n-Escribano B. and Ferrer I. (2009). TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies. J. Neuropathol. Exp. Neurol. 68, 262-273. 10.1097/NEN.0b013e3181996d8f</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181996d8f</ArticleId><ArticleId IdType="pubmed">19225410</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke J. G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A. J., Muhammad A. K. M. G., Ho R., Carmona S., Vit J. P., Zarrow J. et al. (2016). C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324-1329. 10.1126/science.aaf1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott M., Gogvadze V., Orrenius S. and Zhivotovsky B. (2007). Mitochondria, oxidative stress and cell death. Apoptosis 12, 913-922. 10.1007/s10495-007-0756-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-007-0756-2</ArticleId><ArticleId IdType="pubmed">17453160</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Rossi D., Berardinelli A. and Cereda C. (2014). Amyotrophic lateral sclerosis and skeletal muscle: an update. Mol. Neurobiol. 49, 984-990. 10.1007/s12035-013-8578-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8578-4</ArticleId><ArticleId IdType="pubmed">24198230</ArticleId></ArticleIdList></Reference><Reference><Citation>Penke B., Fulop L., Szucs M. and Frecska E. (2018). The role of Sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases. Curr. Neuropharmacol. 16, 97-116. 10.2174/1570159X15666170529104323</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X15666170529104323</ArticleId><ArticleId IdType="pmc">PMC5771390</ArticleId><ArticleId IdType="pubmed">28554311</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A. E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J. R., Schymick J. C., Laaksovirta H., Van Swieten J. C., Myllykangas L. et al. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268. 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo F., Riboldi G., Salani S., Nizzardo M., Simone C., Corti S. and Hedlund E. (2014). Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell. Mol. Life Sci. 71, 999-1015. 10.1007/s00018-013-1480-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1480-4</ArticleId><ArticleId IdType="pmc">PMC3928509</ArticleId><ArticleId IdType="pubmed">24100629</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J. D., Isaacs A. M., Mizielinska S., Mead S., Lashley T., Wray S., Sidle K., Fratta P., Orrell R. W., Hardy J. et al. (2015). C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 14, 291-301. 10.1016/S1474-4422(14)70233-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70233-9</ArticleId><ArticleId IdType="pubmed">25638642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudich P., Snoznik C., Watkins S. C., Monaghan J., Pandey U. B. and Lamitina S. T. (2017). Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans. Hum. Mol. Genet. 26, 4916-4928. 10.1093/hmg/ddx372</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx372</ArticleId><ArticleId IdType="pmc">PMC5886095</ArticleId><ArticleId IdType="pubmed">29036691</ArticleId></ArticleIdList></Reference><Reference><Citation>Salajegheh M., Pinkus J. L., Taylor J. P., Amato A. A., Nazareno R., Baloh R. H. and Greenberg S. A. (2009). Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40, 19-31. 10.1002/mus.21386</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21386</ArticleId><ArticleId IdType="pmc">PMC2700211</ArticleId><ArticleId IdType="pubmed">19533646</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M. L., Julie Corbier C., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E. et al. (2016). Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 35, 1276-1297. 10.15252/embj.201593350</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K. A., Li Y., Chang W.-H., Hung S.-T., Hendricks E., Linares G. R., Wang Y., Son E. Y. et al. (2018). Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 24, 313-325. 10.1038/nm.4490</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallings N. R., Puttaparthi K., Dowling K. J., Luther C. M., Burns D. K., Davis K. and Elliott J. L. (2013). TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS ONE 8, e71793 10.1371/journal.pone.0071793</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071793</ArticleId><ArticleId IdType="pmc">PMC3742534</ArticleId><ArticleId IdType="pubmed">23967244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudria-Lopez E., Koppers M., De Wit M., Van Der Meer C., Westeneng H.-J., Zundel C. A. C., Youssef S. A., Harkema L., De Bruin A., Veldink J. H. et al. (2016). Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. 132, 145-147. 10.1007/s00401-016-1581-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1581-x</ArticleId><ArticleId IdType="pmc">PMC4911370</ArticleId><ArticleId IdType="pubmed">27206760</ArticleId></ArticleIdList></Reference><Reference><Citation>Swartz E. W., Baek J., Pribadi M., Wojta K. J., Almeida S., Karydas A., Gao F.-B., Miller B. L. and Coppola G. (2016). A novel protocol for directed differentiation of C9orf72-associated human induced pluripotent stem cells into contractile skeletal myotubes. Stem Cells Transl. Med. 5, 1461-1472. 10.5966/sctm.2015-0340</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2015-0340</ArticleId><ArticleId IdType="pmc">PMC5070503</ArticleId><ArticleId IdType="pubmed">27369896</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson J. A., Itskovitz-Eldor J., Shapiro S. S., Waknitz M. A., Swiergiel J. J., Marshall V. S. and Jones J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. 10.1126/science.282.5391.1145</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.282.5391.1145</ArticleId><ArticleId IdType="pubmed">9804556</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., King P. H., Si Y., Kwon Y., Varela V., Ibarburu S., Kovacs M., Moura I. C., Beckman J. S., Hermine O. et al. (2018). Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight 3, e123249 10.1172/jci.insight.123249</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xfc;rk M., Haaker G., Winter L., Just W., Nickel F. T., Linker R. A., Chevessier F. and Schr&#xf6;der R. (2014). C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle. Muscle Nerve 50, 454-455. 10.1002/mus.24283</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24283</ArticleId><ArticleId IdType="pubmed">24817207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan S. K., Sutherland N. M., Zhang S., Hatzipetros T., Vieira F. and Valdez G. (2018). The ALS-inducing factors, TDP43A315T and SOD1G93A, directly affect and sensitize sensory neurons to stress. Sci. Rep. 8, 16582 10.1038/s41598-018-34510-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34510-8</ArticleId><ArticleId IdType="pmc">PMC6224462</ArticleId><ArticleId IdType="pubmed">30410094</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Rothstein J. D. and Kiernan M. C. (2014). Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies. Trends Neurosci. 37, 433-442. 10.1016/j.tins.2014.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2014.05.006</ArticleId><ArticleId IdType="pubmed">24927875</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Wander C. M., Yuan C.-X., Bereman M. S. and Cohen T. J. (2017). Acetylation-induced TDP-43 pathology is suppressed by an HSF1-dependent chaperone program. Nat. Commun. 8, 82 10.1038/s41467-017-00088-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00088-4</ArticleId><ArticleId IdType="pmc">PMC5517419</ArticleId><ArticleId IdType="pubmed">28724966</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C. P., Smith E. F., Bauer C. S., Moller A., Hautbergue G. M., Ferraiuolo L., Myszczynska M. A., Higginbottom A., Walsh M. J., Whitworth A. J. et al. (2016a). The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J. 35, 1656-1676. 10.15252/embj.201694401</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C. P., Smith E. F., Grierson A. J. and De Vos K. J. (2016b). C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases 9, 399-408. 10.1080/21541248.2016.1240495</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1240495</ArticleId><ArticleId IdType="pmc">PMC5997165</ArticleId><ArticleId IdType="pubmed">27768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Liang C., Swaminathan K., Herrlinger S., Lai F., Shiekhattar R. and Chen J.-F. (2016). A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2, e1601167 10.1126/sciadv.1601167</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1601167</ArticleId><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Iyer L. M., He F. and Aravind L. (2012). Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front. Genet. 3, 283 10.3389/fgene.2012.00283</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2012.00283</ArticleId><ArticleId IdType="pmc">PMC3521125</ArticleId><ArticleId IdType="pubmed">23248642</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. J., Guo L., Gonzales P. K., Gendron T. F., Wu Y., Jansen-West K., O'raw A. D., Pickles S. R., Prudencio M., Carlomagno Y. et al. (2019). Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science 363, 6428 10.1126/science.aav2606</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2606</ArticleId><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>